Tevogen Research Development from 2010 to 2026
| TVGN Stock | 0.28 0 1.29% |
Research Development | First Reported 2010-12-31 | Previous Quarter 35.7 M | Current Value 37.5 M | Quarterly Volatility 12.4 M |
Check Tevogen Bio financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Tevogen Bio's main balance sheet or income statement drivers, such as Depreciation And Amortization of 281.1 K, Interest Expense of 207.7 K or Selling General Administrative of 27.2 M, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or Days Sales Outstanding of 0.0. Tevogen financial statements analysis is a perfect complement when working with Tevogen Bio Valuation or Volatility modules.
Tevogen | Research Development | Build AI portfolio with Tevogen Stock |
Evaluating Tevogen Bio's Research Development across multiple reporting periods reveals the company's ability to sustain growth and manage resources effectively. This longitudinal analysis highlights inflection points, cyclical patterns, and structural changes that short-term snapshots might miss, offering deeper insight into Tevogen Bio Holdings's fundamental strength.
Latest Tevogen Bio's Research Development Growth Pattern
Below is the plot of the Research Development of Tevogen Bio Holdings over the last few years. It is Tevogen Bio's Research Development historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Tevogen Bio's overall financial position and show how it may be relating to other accounts over time.
| Research Development | 10 Years Trend |
|
Research Development |
| Timeline |
Tevogen Research Development Regression Statistics
| Arithmetic Mean | 8,814,257 | |
| Geometric Mean | 4,859,182 | |
| Coefficient Of Variation | 141.18 | |
| Mean Deviation | 9,147,230 | |
| Median | 2,955,860 | |
| Standard Deviation | 12,444,246 | |
| Sample Variance | 154.9T | |
| Range | 34.5M | |
| R-Value | 0.69 | |
| Mean Square Error | 86.9T | |
| R-Squared | 0.47 | |
| Significance | 0 | |
| Slope | 1,696,662 | |
| Total Sum of Squares | 2477.7T |
Tevogen Research Development History
About Tevogen Bio Financial Statements
Tevogen Bio investors utilize fundamental indicators, such as Research Development, to predict how Tevogen Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Research Development | 35.7 M | 37.5 M |
Pair Trading with Tevogen Bio
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Tevogen Bio position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Tevogen Bio will appreciate offsetting losses from the drop in the long position's value.Moving together with Tevogen Stock
Moving against Tevogen Stock
| 0.85 | DRTS | Alpha Tau Medical | PairCorr |
| 0.77 | 6C1 | CytomX Therapeutics | PairCorr |
| 0.74 | EQ | Equillium | PairCorr |
| 0.67 | GXEA | Galapagos NV Earnings Call This Week | PairCorr |
| 0.65 | DSGN | Design Therapeutics | PairCorr |
The ability to find closely correlated positions to Tevogen Bio could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Tevogen Bio when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Tevogen Bio - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Tevogen Bio Holdings to buy it.
The correlation of Tevogen Bio is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Tevogen Bio moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Tevogen Bio Holdings moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Tevogen Bio can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out the analysis of Tevogen Bio Correlation against competitors. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
Will Biotechnology sector continue expanding? Could Tevogen diversify its offerings? Factors like these will boost the valuation of Tevogen Bio. If investors know Tevogen will grow in the future, the company's valuation will be higher. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Tevogen Bio data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Investors evaluate Tevogen Bio Holdings using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Tevogen Bio's intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. External factors like market trends, sector rotation, and investor psychology can cause Tevogen Bio's market price to deviate significantly from intrinsic value.
Please note, there is a significant difference between Tevogen Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Tevogen Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. Conversely, Tevogen Bio's market price signifies the transaction level at which participants voluntarily complete trades.